The relationship between coronary stent strut thickness and the incidences of clinical outcomes after drug‐eluting stent implantation: A systematic review and meta‐regression analysis
- 22 August 2021
- journal article
- review article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 99 (3) , 575-582
Abstract
Background: Drug‐eluting stents (DESs) have been developed with thinner stent struts, and more biocompatible polymers and anti‐proliferative drugs to improve the clinical performance. However, it remains unclear whether thinner struts are associated with favorable short‐ and long‐term clinical outcomes such as target lesion revascularization (TLR), periprocedural myocardial infarction (PMI), and stent thrombosis (ST).Methods: We searched MEDLINE, Embase and other online sources for randomized controlled trials (RCTs) comparing clinical outcomes between a DES and other stent(s), with independent clinical event adjudication. We investigated stent‐related events (TLR, PMI, and ST) in 5 years. Each outcome was analyzed with random‐effects meta‐regression model against strut thickness, then adjusted for DES generation and patient and lesion characteristics.Results: We identified 49 RCTs enrolling 97,465 patients, of which strut thickness ranged from 60 to 140 μm. Incidences of 1‐year TLR, PMI, and early ST were reduced with thinner stent struts, when adjusted for stent generation (adjusted relative risk [RR] per 10 μm increase 1.12 [95% CI 1.04–1.21], 1.15 [95% CI 1.05–1.26], and 1.15 [95% CI 1.06–1.25], respectively). Strut thickness was not independently associated with incidences of 5‐year TLR, late and very late ST. In addition, early DESs contributed to a higher incidence of very late ST (adjusted RR 2.97 [95% CI 1.36–6.50]).Conclusions: In this meta‐regression analysis, a thinner strut thickness was associated with reduced incidences of early stent‐related adverse events (1‐year TLR, PMI, and early ST), but not with later events (5‐year TLR, late ST, and very late ST).Keywords
This publication has 29 references indexed in Scilit:
- Role of Endothelial Shear Stress in Stent Restenosis and ThrombosisJACC, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Meta-Analysis and Systematic Review of the Long-Term Predictive Value of Assessment of Coronary Atherosclerosis by Contrast-Enhanced Coronary Computed Tomography AngiographyJACC, 2011
- Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug CoatingsCirculation, 2011
- Periprocedural Myocardial InfarctionCirculation: Cardiovascular Interventions, 2010
- Hemodynamically Driven Stent Strut DesignAnnals of Biomedical Engineering, 2009
- Frequency and Clinical Consequences Associated With Sidebranch Occlusion During Stent Implantation Using Zotarolimus-Eluting and Paclitaxel-Eluting Coronary StentsCirculation: Cardiovascular Interventions, 2009
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Mechanotransduction and endothelial cell homeostasis: the wisdom of the cellAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Isolated Elevation in Troponin T After Percutaneous Coronary Intervention Is Associated With Higher Long-Term MortalityJACC, 2006